Jorge F Saucedo - JoVE Visualize

Showing results (51-60 of 70) with videos related to

Pageof 7

Sort By:

Circulation|September 25, 2003

Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudicationSanjay Rajagopalan, Emile R Mohler, Robert J Lederman, et al.

Journal of Thrombosis and Thrombolysis|May 10, 2012

Pharmacodynamic effects of cangrelor and clopidogrel: the platelet function substudy from the cangrelor versus standard therapy to achieve optimal management of platelet inhibition (CHAMPION) trialsDominick J Angiolillo, David J Schneider, Deepak L Bhatt, et al.

Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 21, 2012

In-hospital and 1-year outcomes with drug-eluting versus bare metal stents in saphenous vein graft intervention: a report from the EVENT registryPaul H Tolerico, David J Cohen, Neal S Kleiman, et al.

Cardiovascular Revascularization Medicine : Including Molecular Interventions|June 27, 2026

AI-enhanced ECG for acute coronary syndrome triage: A state-of-the-art reviewKeshav Garg, Vidhi Bhanushali, Nitesh Gautam, et al.

Lancet (London, England)|June 28, 2002

Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trialRobert J Lederman, Farrell O Mendelsohn, R David Anderson, et al.

The American Journal of Cardiology|September 17, 2002

Comparison of one-year outcomes following coronary artery stenting in diabetic versus nondiabetic patients (from the Enhanced Suppression of the Platelet IIb/IIIa Receptor With Integrilin Therapy [ESPRIT] Trial)Marino Labinaz, Mina Madan, J O'Conor O'Shea, et al.

The American Journal of Cardiology|April 15, 2004

Bradycardia during therapy for multiple myeloma with thalidomideIbrahim Elias Fahdi, Venkat Gaddam, Jorge F Saucedo, et al.

The American Journal of Cardiology|May 5, 2007

Changes in patterns of coronary revascularization strategies for patients with acute coronary syndromes (from the CRUSADE Quality Improvement Initiative)Prospero B Gogo, Harold L Dauerman, Jyotsna Mulgund, et al.

Journal of the American Heart Association|March 31, 2026

Implementing the GWTG-CAD Program in Mexico: Feasibility, Challenges and Lessons Learned for Acute and Secondary Prevention and ManagementLeslie Marisol Lugo-Gavidia, Jorge F Saucedo, Alexandra Arias-Mendoza, et al.

American Heart Journal|July 11, 2006

Clinical characteristics, process of care, and outcomes of Hispanic patients presenting with non-ST-segment elevation acute coronary syndromes: results from Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines (CRUSADE)Mauricio G Cohen, Matthew T Roe, Jyotsna Mulgund, et al.

Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:

Pageof 7

Circulation|September 25, 2003

Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudicationSanjay Rajagopalan, Emile R Mohler, Robert J Lederman, et al.

Journal of Thrombosis and Thrombolysis|May 10, 2012

Pharmacodynamic effects of cangrelor and clopidogrel: the platelet function substudy from the cangrelor versus standard therapy to achieve optimal management of platelet inhibition (CHAMPION) trialsDominick J Angiolillo, David J Schneider, Deepak L Bhatt, et al.

Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 21, 2012

In-hospital and 1-year outcomes with drug-eluting versus bare metal stents in saphenous vein graft intervention: a report from the EVENT registryPaul H Tolerico, David J Cohen, Neal S Kleiman, et al.

Cardiovascular Revascularization Medicine : Including Molecular Interventions|June 27, 2026

AI-enhanced ECG for acute coronary syndrome triage: A state-of-the-art reviewKeshav Garg, Vidhi Bhanushali, Nitesh Gautam, et al.

Lancet (London, England)|June 28, 2002

Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trialRobert J Lederman, Farrell O Mendelsohn, R David Anderson, et al.

The American Journal of Cardiology|September 17, 2002

Comparison of one-year outcomes following coronary artery stenting in diabetic versus nondiabetic patients (from the Enhanced Suppression of the Platelet IIb/IIIa Receptor With Integrilin Therapy [ESPRIT] Trial)Marino Labinaz, Mina Madan, J O'Conor O'Shea, et al.

The American Journal of Cardiology|April 15, 2004

Bradycardia during therapy for multiple myeloma with thalidomideIbrahim Elias Fahdi, Venkat Gaddam, Jorge F Saucedo, et al.

The American Journal of Cardiology|May 5, 2007

Changes in patterns of coronary revascularization strategies for patients with acute coronary syndromes (from the CRUSADE Quality Improvement Initiative)Prospero B Gogo, Harold L Dauerman, Jyotsna Mulgund, et al.

Journal of the American Heart Association|March 31, 2026

Implementing the GWTG-CAD Program in Mexico: Feasibility, Challenges and Lessons Learned for Acute and Secondary Prevention and ManagementLeslie Marisol Lugo-Gavidia, Jorge F Saucedo, Alexandra Arias-Mendoza, et al.

American Heart Journal|July 11, 2006

Clinical characteristics, process of care, and outcomes of Hispanic patients presenting with non-ST-segment elevation acute coronary syndromes: results from Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines (CRUSADE)Mauricio G Cohen, Matthew T Roe, Jyotsna Mulgund, et al.

Pageof 7